Genomictree Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

genomictree.com

Country

South Korea

Exchange

KOSDAQ

Founded 2000Daejeon, South Korea

Genomictree Inc., a biomarker-based molecular diagnostics company develops and commercializes molecular diagnostic products for the detection of cancer and various infectious diseases. The company offers EarlyTect C, a screening method for early diagnosis of colorectal cancer.

Its portfolio also includes EarlyTect L for detection of epigenetic markers associated with lung cancer in pulmonary nodule patients, and EarlyTect B for detection of genetic and epigenetic markers associated with bladder cancer in hematuria patients AccuraDTect SARS-CoV-2 RT-qPCR kits, test providers, and nucleic acid transport medium products. Founded in 2000, the company is headquartered in Daejeon, South Korea.

Key Stats

52-Week Range

₩10010.00₩33300.00

Beta2.25

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.